ImetelChat

Thanks for posting guys. I was tied up and unable to listen to presentation but will definitely do so when replay posted on the Geron site. Jay, you mention Dr. S asserting commercialization in first half of 2024 but given the delay and time for preparation, couldn’t they start selling the next day ...

KT, you can be sure the new CFO and CLO did not jump onto a sinking ship. If anything they added floatation material. Additionally new medical writer position posted recently. So where are the articles? We used to write our own articles and do give our data to the statisticians. The research of cour...

Geron did receive an “Honorable Distinction” award for the MDS presentation. Since this data had been presented previously in an oral presentation at EHA, I don’t think it could qualify for a major presentation at SOHO, not sure about this but usually major presentations at meetings must be new, and...

Ryan, yes Momenta had many irons in the fire. I followed them for their low molecular weight heparin operation as well as the allergy/immunology program. True to form I sold all of my Momenta to buy more Geron just before the walk (and of course before the J and J acquisition) . We know how that wen...

Thank you Olivia and welcome Michelle!

LWS, I agree the medical data and the KOL’s presentations appear very positive. I was extremely disappointed that the FDA failed to grant priority review and continue to wonder why that occurred. Getting an NDA accepted even with standard review is an accomplishment but having a drug that can restor...

LWS, there is plenty wrong with circumstantial evidence, particularly since it is speculative and not concrete. When you state this or that company has an interest in Geron that is speculation and should be labeled as such.

LWS, I fail to see the strong support of the either J and J or Abbvie you cite. Individuals who previously worked at J and J have come to Geron in droves but these are individuals and do not necessarily represent what J and J management is thinking. I hope they are thinking of Geron but there does n...

Look forward to welcoming you to the board but I am not seeing your registration request. Please be sure to use the same user name and let me know approximate date and time you have registered. I will keep looking. bp

Saltrock, thank you for your kind words. This board had given me an opportunity to make friends from around the world, I will number you among them. bp

Jay yes a review (some might say rehash) of EHA data.Disease modification, durability and symptom reduction a good thing to revisit.

HI you are correct. Primary completion anticipated in Jan 2024 but that may not equate to top line data presentation which should follow probably later.

HI, Agreed on all counts, Dr. Scarlett did guide early safety data (and maybe early clinical data) for IMprove study. Would also add that preclinical update on development of oral telomerase inhibitor is due. As to Ryan’s speculation, at the very least IMpress enrollment update but would hope for so...

Thank you kmall, much appreciated. bp

I suppose suffering a few slings and arrows is part of the “job”. A few thoughts though: 1. I serve strictly as a volunteer moderator on this board. If you can do better, step up. 2. If you don’t like what you read here, don’t visit. As my 8th grade shop teacher said, “you like it—good. You don’t li...

Image a world without Imetelchat! We would be left with the black hole of YMB!! In my (admittedly weak defense of my misquote, I have had two beloved very close relatives hospitalized in the last few days with severe heart issues and two other relatives with cancer scares one of which turned out to ...

Ack! My error. Of course it was Yogi. I stand corrected. Thank you Bridge.

To quote Joe D, it’s deja vu all over again.

LWS it’s right there, just click on the author.

Saltrock, I didn’t actually look at the expiration date of the options you referred to. Were they close to expiration? There is nothing wrong with exercising options and taking a profit. Also to those who complain about lack of insider buying. There is no way that can happen except through predeterm...